Wendell Amy McBride

Solventum Corporation Common Stock · Director

Wendell Amy McBride is listed in filings as Director at Solventum Corporation Common Stock. This profile follows SEC Form 4 activity through May 18, 2026, including sale activity and purchase activity. Recent filings connect the profile to Solventum Corporation Common Stock (SOLV), AxoGen, Inc. (AXGN), Baxter International Inc (BAX), and Hologic Inc (HOLX). The current snapshot covers public activity from Sep 4, 2024 to May 18, 2026. Reported amounts are shown as $70.2K to $372.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Data sources and methodology

History Trades

CompanyValueActionPriceLast Price
Solventum Corporation Common StockSOLV$100k1.5k sharesBuyMar 10, 2026$68.03$75.89
AxoGen, Inc.AXGN$599k20.4k sharesSellDec 16, 2025$29.31$39.87
AxoGen, Inc.AXGN$535k18.2k sharesSellDec 16, 2025$29.31$39.87
AxoGen, Inc.AXGN$147k5k sharesSellDec 16, 2025$29.31$39.87
AxoGen, Inc.AXGN$43k4.1k sharesSellJun 9, 2025$10.61$39.87
AxoGen, Inc.AXGN$100k5k sharesSellMar 3, 2025$20.02$39.87